Back to Index
Pengfei Xu
Postdoctoral Scholar Research Associate
Stem Cell Biology & Regenerative Medicine
BCC 1425 San Pablo St. Rm 403 Health Sciences Campus Los Angeles


Randomized Phase Ib/II Study of Gemcitabine Plus Placebo or Vismodegib, a Hedgehog Pathway Inhibitor, in Patients With Metastatic Pancreatic Cancer. J Clin Oncol. 2015 Dec 20; 33(36):4284-92. View in: PubMed

Powered bySC CTSI